GSK, Sanofi begin new Covid-19 vaccine trial after setback last year
In this photo illustration the British multinational pharmaceutical company GlaxoSmithKline (GSK) logo seen displayed on a smartphone with a computer model of the COVID-19 coronavirus on the background. Budrul Chukrut | SOPA Images | Getty Images Britain’s GlaxoSmithKline and France’s Sanofi on Monday said they had started a new clinical trial of their protein-based Covid-19 […]
Continue Reading